Australia, March 31 -- Glaxo Group Ltd., owns the trademark (2591760) for 'CAYMNIRV' till Sept. 5, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: Oct. 10, 2025
Registration Advertised: March 30
For further details contact Legal Brand Protection.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2591760.
Disclaimer: Curated by HT Syndication.
